A Randomized, Double-blind, Placebo Controlled, Exploratory Study to Assess the Safety and Efficacy of Multiple Doses of ACZ885 in Chronic Obstructive Pulmonary Disease (COPD) Patients.
Phase of Trial: Phase I/II
Latest Information Update: 29 Jun 2011
At a glance
- Drugs Canakinumab (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 27 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Aug 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 09 Feb 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.